Remedy publishes the financial statements release, two business reviews and the half-year review according to the disclosed annual schedule.
|Silent period and closed window||12.1.–11.2.2022|
|Financial statements release 2021||11.2.2022|
|Annual report, financial statements, Board of Directors’ report and Audit report for 2021||Week 12 / 2022|
|Silent period and closed window||13.4.–13.5.2022|
|Annual General Meeting 2022||13.4.2022|
|Business review for January-March 2022||13.5.2022|
|Silent period and closed window||13.7.–12.8.2022|
|Half-year review for January-June 2022||12.8.2022|
|Silent period and closed window||28.9.–28.10.2022|
|Business review for January-September 2022||28.10.2022|
Regularly published financial reports are always preceded by a silent period of 30 days, during which Remedy does not issue statements on the financial position, business operations, markets or prospects.
During the silent period, the senior management of the company does not meet with investors, analysts or other capital market representatives, nor do they give interviews on the financial position of the company.